Comac Medical will attend the dynamic MEET2WIN Oncology Partnering Convention 2024, taking place on 16th to 17th of May in Bordeaux, France. This event serves as a collaborative hub, uniting professionals from academia, industry, and healthcare to accelerate innovation and improve outcomes in oncology.  

In 2023, MEET2WIN welcomed over 400 attendees from 12 countries, including researchers, clinicians, biotech companies, and investors. With more than 1,200 scheduled one-on-one meetings and insightful sessions on oncology advancements, the convention proved to be a powerful platform for networking and forming impactful partnerships.  

At MEET2WIN 2024, our representatives Christ Serra, VP of Business Development and Biljana Stuparevic, Business Development Specialist, will engage with global experts, share Comac Medical’s expertise in oncology clinical trials, and explore opportunities for collaboration. Our goal is to foster connections that drive innovation and deliver life-changing therapies to patients worldwide.  

For over 25 years, Comac Medical has specialized in clinical trial management, with strengths in patient recruitment, site selection, and regulatory affairs. We focus on supporting oncology research from early to late phases, ensuring high-quality results and faster timelines for our partners.  

Read more about our oncology experience here.

We look forward to connecting with you in Bordeaux and working together to advance oncology care. Meet us there to transform cancer research and make a lasting impact.